EV battery maker Northvolt has filed for bankruptcy in Sweden after making an “exhaustive effort” to secure a viable future.

Novo Nordisk (CSE:NOVOb) (NYSE:NVO) shares slumped Wednesday after Roche (SIX:ROG) struck a $5.3 billion deal to acquire rights to an obesity treatment from Denmark’s Zealand Pharma A/S (CSE:ZELA).

European markets closed higher on Wednesday after the EU imposed retaliatory tariffs on imports of steel and aluminium from ...

European markets are heading for a sharply higher open amid hopes that a ceasefire can be reached to pause the war in Ukraine.

The rest of Europe could learn from them. Politicians in Brussels are perpetually searching for ways to invigorate the ...

Former U.S. President Donald Trump has reignited the debate over the Keystone XL Pipeline, expressing his desire to see the project revived and completed. In recent statements made via social media, ...

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer. Hims & Hers Health Inc.’s stock plunged last week when the ...

Investing.com -- Novo Nordisk shares climbed more than 3% premarket on Tuesday after Hims&Hers Health announced it may no longer sell compounded versions of semaglutide, the active ingredient in ...

Revenues in the biopharma industry continued to boom in the fourth quarter of last year, following a pattern seen increasingly throughout 2024. Of the world’s 22 biopharma companies that had ...

In response to the Hims & Hers TV ad, Novo Nordisk — the manufacturer of Ozempic and Wegovy — put out a print ad in the New York Times and USA Today stating, “Do you really know what you ...

TD Cowen projects that with Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) continuing their dominance, global sales of the GLP-1 class of weight loss/obesity drugs could reach $139B by 2030 ...

Novo can now meet the demand for Ozempic and Wegovy nationwide, the Food and Drug Administration said Friday. The ruling shows Novo’s confidence that the supply of Ozempic will be stable for now.